Information
- Information
Article on Joint Research Agreement Between Elix and Axcelead DDP on Targeted Protein Degraders Featured in Daily Yakugyo
- News Release
Elix and Axcelead DDP Enter into Collaborative Research Agreement to Advance Targeted Protein Degrader Discovery: Combining AI Drug Discovery Technologies with Drug Discovery Expertise to Advance Solutions for Challenging Targets
- Information
Article on Joint Research with University of Vienna Using AI and NMR Featured in Nikkei Biotech ONLINE
- Information
Articles on the Joint Research Agreement Between Elix and the University of Vienna for AI-Driven Drug Discovery Featured in International Media
- News Release
Elix, an AI Drug Discovery Company and University of Vienna Enter into Joint Research Agreement to Advance Drug Discovery Using AI Technology
- Information
Elix will exhibit at the AI-Driven Drug Discovery Forum on July 14
- Information
Our CEO, Shinya, Will Give a Presentation at the Technology Seminar of the 30th Annual Meeting of the Japanese Association for Molecular Target Therapy of Cancer
- Information
Elix will participate in partnering program at “BIO KOREA 2026” held in Seoul from April 28 to 30
- Information
Elix will give a joint presentation with Mitsubishi Corporation at the Science Cafe at Shonan iPark on April 23.